The investigations are widespread: They span 71 major medical centers and research institutions, and 24 of the cases have been referred to HHS’ Office of Inspector General for alleged criminal activity, according to the report. About 12 scientists have already resigned or been fired from institutions including MD Anderson Cancer Center in Houston, Nationwide Children’s Hospital in Columbus and Emory University in Atlanta.
“You could take a dart board with medical colleges with significant research programs and, as far as I can tell, you’d have a 50-50 chance of hitting a school with an active case,” Ross McKinney Jr., MD, chief scientific officer of the Association of American Medical Colleges, told The New York Times.
The cases involve alleged theft of research that could lead to new treatments or tools, according to the report. Some cases involve scientists patenting technology in China that was developed in the U.S. with government grants. Others involve alleged Chinese labs set up to replicate American research, according to the report.
However, the issue has drawn criticism from people who say Chinese and Chinese American scientists are now being unfairly targeted, according to the report.
Read the full story here.
More articles on leadership and management:
Growing diversity and leadership within the healthcare industry: 4 insights
Efforts to undo Trump’s ACA changes killed in Senate
How UMass Memorial Health Care deployed a successful telehealth strategy
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
